Faron Pharmaceuticals expands R&D strategy for Clevegen
26 May 2016 | By Victoria White, Digital Content Producer
Faron aims to extend the range of Clevegen indications through a technology platform called “Tumour Immunity Enabling Technology”, or TIET...